QDEL - Quidel Corporation
NASDAQ
->
Healthcare
->
Diagnostics & Research
San Diego,
United States
Type: Equity
QDEL price evolution
QDEL
| (in millions $) | 31 Jan 2024 | 2 Aug 2023 | 2 May 2023 | 1 Feb 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.9 | $149.3 | $178.6 | $353.9 |
| Short term investments | $48.4 | $43.9 | $45.1 | $42.8 |
| Net receivables | $303.3 | $426.6 | $454.7 | $542.1 |
| Inventory | $577.8 | $542.2 | $528.6 | $524.1 |
| Total current assets | $1310.5 | $1308.1 | $1498.9 | $1575.1 |
| Long term investments | $7.4 | $11.9 | $24.7 | $33.8 |
| Property, plant & equipment | $1613.4 | $1553.6 | $1541.1 | $1520 |
| Goodwill & intangible assets | $5426.3 | $5419.4 | $5506.6 | $5569.8 |
| Total noncurrent assets | $7252.6 | $7167.8 | $7242.2 | $7288.2 |
| Total investments | $55.8 | $55.8 | $69.8 | $76.6 |
| Total assets | $8563.1 | $8550.3 | $8787.1 | $8855.8 |
| Current liabilities | ||||
| Accounts payable | $294.8 | $225.9 | $241.5 | $283.3 |
| Deferred revenue | ||||
| Short long term debt | $139.8 | $193 | $207.4 | $207.5 |
| Total current liabilities | $1006.6 | $790 | $907.8 | $1007 |
| Long term debt | $2274.8 | $2308.5 | $2379.6 | $2430.8 |
| Total noncurrent liabilities | $2723.4 | $2712.4 | $2757.8 | $2882.8 |
| Total debt | $2587.4 | $2643.5 | $2697.1 | $2770.4 |
| Total liabilities | $3557.2 | $3547.8 | $3790.6 | $3921.2 |
| Shareholders' equity | ||||
| Retained earnings | $2187.8 | $2193.5 | $2246.7 | $2197.9 |
| Other shareholder equity | $5005.9 | -$15.9 | -$59 | -$67.67 |
| Total shareholder equity | $5005.9 | $4966.7 | $5002.5 | $4996.5 |
| (in millions $) | 31 Jan 2024 | 1 Feb 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $118.9 | $292.9 | $802.75 | $489.94 |
| Short term investments | $48.4 | $52.1 | $25.76 | |
| Net receivables | $303.3 | $542.1 | $377.97 | $497.69 |
| Inventory | $577.8 | $524.1 | $198.76 | $113.8 |
| Total current assets | $1310.5 | $1575.1 | $1440.31 | $1142.4 |
| Long term investments | $7.4 | $21 | $37.85 | |
| Property, plant & equipment | $1613.4 | $1520 | $476.82 | $211.03 |
| Goodwill & intangible assets | $5426.3 | $5600.6 | $435.68 | $459.46 |
| Total noncurrent assets | $7252.6 | $7280.7 | $990.06 | $728.76 |
| Total investments | $55.8 | $73.1 | $63.61 | |
| Total assets | $8563.1 | $8855.8 | $2430.37 | $1871.16 |
| Current liabilities | ||||
| Accounts payable | $294.8 | $283.3 | $101.49 | $86.32 |
| Deferred revenue | ||||
| Short long term debt | $139.8 | $207.5 | $10.04 | $7.8 |
| Total current liabilities | $1006.6 | $1007 | $323.52 | $336.96 |
| Long term debt | $2274.8 | $2430.8 | $128.56 | $100.71 |
| Total noncurrent liabilities | $2723.4 | $2914.2 | $177.49 | $201.5 |
| Total debt | $2587.4 | $2824.7 | $138.59 | $108.5 |
| Total liabilities | $3557.2 | $3921.2 | $501.01 | $538.46 |
| Shareholders' equity | ||||
| Retained earnings | $2187.8 | $2197.9 | $1649.2 | $944.97 |
| Other shareholder equity | $5005.9 | $2.13 | $0.35 | -$0.43 |
| Total shareholder equity | $5005.9 | $4934.6 | $1929.36 | $1332.7 |
| (in millions $) | 31 Jan 2024 | 2 Aug 2023 | 2 May 2023 | 1 Feb 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $742.6 | $665.1 | $846.1 | $866.5 |
| Cost of revenue | ||||
| Gross Profit | $381.3 | $296.4 | $448.6 | $449 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | ||||
| Total operating expenses | $308.2 | $299.1 | $319.3 | $336.1 |
| Operating income | ||||
| Income from continuing operations | ||||
| EBIT | ||||
| Income tax expense | -$16.2 | -$11.2 | $11.2 | $10.8 |
| Interest expense | -$36.7 | -$36.5 | -$36.7 | -$34.7 |
| Net income | ||||
| Net income | $7 | -$53.2 | $48.8 | $30.3 |
| Income (for common shares) | ||||
| (in millions $) | 31 Jan 2024 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2997.8 | $3266 | $1698.55 | $1661.67 |
| Cost of revenue | $1330 | $427.66 | $312.81 | |
| Gross Profit | $1494.4 | $1936 | $1270.89 | $1348.86 |
| Operating activities | ||||
| Research & development | $190.5 | $95.7 | $84.29 | |
| Selling, general & administrative | $621 | $259.57 | $200.54 | |
| Total operating expenses | $1241.9 | $1092.3 | $364.83 | $288.53 |
| Operating income | $843.7 | $906.07 | $1060.33 | |
| Income from continuing operations | ||||
| EBIT | $811.6 | $906.07 | $1049.94 | |
| Income tax expense | -$19 | $187.2 | $196.13 | $230.03 |
| Interest expense | -$147.6 | $75.7 | $5.71 | $9.62 |
| Net income | ||||
| Net income | -$10.1 | $548.7 | $704.23 | $810.29 |
| Income (for common shares) | $548.7 | $704.23 | $810.29 | |
| (in millions $) | 31 Dec 2023 | 2 Aug 2023 | 2 May 2023 | 1 Feb 2023 |
|---|---|---|---|---|
| Net income | $7 | |||
| Operating activities | ||||
| Depreciation | $115.4 | |||
| Business acquisitions & disposals | ||||
| Stock-based compensation | $12.3 | |||
| Total cash flows from operations | $80.4 | |||
| Investing activities | ||||
| Capital expenditures | -$45.6 | |||
| Investments | $0.5 | |||
| Total cash flows from investing | -$55.1 | -$111.2 | -$68.9 | -$1644.2 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$3.7 | |||
| Net borrowings | -$53.6 | |||
| Total cash flows from financing | -$57.8 | -$159.3 | -$59.6 | $252 |
| Effect of exchange rate | $2.1 | -$2.1 | $0.6 | -$2 |
| Change in cash and equivalents | -$30.4 | -$114.3 | $61 | -$508.9 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | -$10.1 | $548.7 | $704.23 | $810.29 |
| Operating activities | ||||
| Depreciation | $457.2 | $283.6 | $54.38 | $49.09 |
| Business acquisitions & disposals | -$1511.4 | |||
| Stock-based compensation | $51.6 | $48.4 | $25.41 | $21.02 |
| Total cash flows from operations | $280.2 | $885.3 | $805.87 | $629.76 |
| Investing activities | ||||
| Capital expenditures | -$195.8 | -$122.5 | -$255.84 | -$63.32 |
| Investments | $18.2 | -$10.3 | -$63.69 | |
| Total cash flows from investing | -$187.6 | -$1644.2 | -$319.53 | -$63.32 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | $4.4 | -$47.9 | -$95.89 | -$38.28 |
| Net borrowings | -$226.4 | $346.2 | -$0.26 | -$43.96 |
| Total cash flows from financing | -$265.8 | $252 | -$173.18 | -$130.28 |
| Effect of exchange rate | -$1.2 | -$2 | -$0.35 | $1 |
| Change in cash and equivalents | -$174.4 | -$508.9 | $312.81 | $437.17 |
News
Fundamentals
| Market cap | $2.73B |
|---|---|
| Enterprise value | $5.20B |
| Shares outstanding | 66.82M |
| Revenue | $3.12B |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | $32.90M |
| Revenue Q/Q | -5.26% |
| Revenue Y/Y | 3.57% |
| P/E ratio | 82.90 |
|---|---|
| EV/Sales | 1.67 |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | 0.87 |
| P/B ratio | InfinityT |
| Book/Share | 0.00 |
| Cash/Share | 1.78 |
| EPS | $0.49 |
|---|---|
| ROA | 0.38% |
| ROE | 0.66% |
| Debt/Equity | 0.71 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 1.30 |
| Quick ratio | 0.73 |